Skip to content

Heparin vs Placebo for Cardiac Catheterization

Cardiac Disease

Patients undergoing cardiac catheterization will be randomized to 3 groups: no anticoagulant, low dose anticoagulant and high dose anticoagulant.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:

* diagnostic cardiac catheterization; Small size sheath; patency of the ulno-palmar circulation

Exclusion Criteria:

abnormal ulno-palmar circulation; Prior radial artery thrombosis; Prior surgery close to the access site; Emergent cardiac catheterization; History of HIT or allergy to heparin; Patients requiring anticoagulation

Lieu de l'étude

London Health Sciences Centre
London Health Sciences Centre
London, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Shahar Lavi, MD

[email protected]
519-663-3611
Backup Contact

Cassandra Wagner, MSc

[email protected]
519-685-8500
Hamilton Health Sciences
Hamilton Health Sciences
Hamilton, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Shamir Mehta

Étude parrainée par
London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's
Participants recherchés
Plus d'informations
ID de l'étude: NCT04374799